BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 12665631)

  • 1. Proposal for a unified CCN nomenclature.
    Brigstock DR; Goldschmeding R; Katsube KI; Lam SC; Lau LF; Lyons K; Naus C; Perbal B; Riser B; Takigawa M; Yeger H
    Mol Pathol; 2003 Apr; 56(2):127-8. PubMed ID: 12665631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CCN family: a new stimulus package.
    Brigstock DR
    J Endocrinol; 2003 Aug; 178(2):169-75. PubMed ID: 12904165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.
    Lin CG; Leu SJ; Chen N; Tebeau CM; Lin SX; Yeung CY; Lau LF
    J Biol Chem; 2003 Jun; 278(26):24200-8. PubMed ID: 12695522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
    Lin CG; Chen CC; Leu SJ; Grzeszkiewicz TM; Lau LF
    J Biol Chem; 2005 Mar; 280(9):8229-37. PubMed ID: 15611078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61).
    Brigstock DR
    Angiogenesis; 2002; 5(3):153-65. PubMed ID: 12831056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells.
    Leu SJ; Lam SC; Lau LF
    J Biol Chem; 2002 Nov; 277(48):46248-55. PubMed ID: 12364323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYR61 (CCN1) is essential for placental development and vascular integrity.
    Mo FE; Muntean AG; Chen CC; Stolz DB; Watkins SC; Lau LF
    Mol Cell Biol; 2002 Dec; 22(24):8709-20. PubMed ID: 12446788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina.
    Hughes JM; Kuiper EJ; Klaassen I; Canning P; Stitt AW; Van Bezu J; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Diabetologia; 2007 May; 50(5):1089-98. PubMed ID: 17333105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.
    Jiang WG; Watkins G; Fodstad O; Douglas-Jones A; Mokbel K; Mansel RE
    Endocr Relat Cancer; 2004 Dec; 11(4):781-91. PubMed ID: 15613452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.
    Xie D; Nakachi K; Wang H; Elashoff R; Koeffler HP
    Cancer Res; 2001 Dec; 61(24):8917-23. PubMed ID: 11751417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and regulation of CCN genes in murine osteoblasts.
    Parisi MS; Gazzerro E; Rydziel S; Canalis E
    Bone; 2006 May; 38(5):671-7. PubMed ID: 16311085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis and therapeutic implication of the interaction of CCN proteins with glycoconjugates.
    Desnoyers L
    Curr Pharm Des; 2004; 10(31):3913-28. PubMed ID: 15579080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia.
    Yu C; Le AT; Yeger H; Perbal B; Alman BA
    J Pathol; 2003 Dec; 201(4):609-15. PubMed ID: 14648665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas.
    Xie D; Yin D; Wang HJ; Liu GT; Elashoff R; Black K; Koeffler HP
    Clin Cancer Res; 2004 Mar; 10(6):2072-81. PubMed ID: 15041728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.
    Perbal B
    Mol Pathol; 2001 Apr; 54(2):57-79. PubMed ID: 11322167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in the study of CCN family].
    Su BY; Cai WQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):179-83. PubMed ID: 12390824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCN proteins and cancer: two to tango.
    Bleau AM; Planque N; Perbal B
    Front Biosci; 2005 May; 10():998-1009. PubMed ID: 15769600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CCN family of genes: a perspective on CCN biology and therapeutic potential.
    Yeger H; Perbal B
    J Cell Commun Signal; 2007 Dec; 1(3-4):159-64. PubMed ID: 18568428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCN3 and calcium signaling.
    Lombet A; Planque N; Bleau AM; Li CL; Perbal B
    Cell Commun Signal; 2003 Aug; 1(1):1. PubMed ID: 14606958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis.
    Croci S; Landuzzi L; Nicoletti G; Palladini A; Antognoli A; De Giovanni C; Nanni P; Lollini PL
    Pathol Oncol Res; 2007; 13(4):336-9. PubMed ID: 18158569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.